Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $28 Million - $32.5 Million
251,800 New
251,800 $28.6 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $6.8 Million - $7.4 Million
67,900 Added 211.53%
100,000 $10.9 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $3.3 Million - $3.67 Million
32,100 New
32,100 $3.3 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $3.48 Million - $3.88 Million
33,800 Added 43.11%
112,200 $11.9 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $6.54 Million - $8.39 Million
74,800 Added 2077.78%
78,400 $8.6 Million
Q3 2022

Nov 15, 2022

SELL
$84.53 - $94.96 $23 Million - $25.8 Million
-271,600 Reduced 98.69%
3,600 $314,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $21.4 Million - $24.3 Million
256,700 Added 1387.57%
275,200 $25.4 Million
Q1 2022

May 18, 2022

SELL
$73.51 - $82.4 $7.09 Million - $7.95 Million
-96,500 Reduced 83.91%
18,500 $1.56 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $84.6 Million - $96.5 Million
-1,215,900 Reduced 91.36%
115,000 $9.39 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $74.5 Million - $87.6 Million
1,291,000 Added 3235.59%
1,330,900 $94.8 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $351,624 - $408,687
-6,900 Reduced 14.74%
39,900 $2.18 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $2.03 Million - $2.36 Million
39,900 Added 578.26%
46,800 $2.75 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $1.45 Million - $1.73 Million
-28,100 Reduced 80.29%
6,900 $572,000
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $2.05 Million - $2.21 Million
35,000
35,000 $2.25 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.